134 related articles for article (PubMed ID: 6343068)
1. Review: putative mutagens and carcinogens in foods. III. Butylated hydroxytoluene (BHT).
Malkinson AM
Environ Mutagen; 1983; 5(3):353-62. PubMed ID: 6343068
[TBL] [Abstract][Full Text] [Related]
2. Effect of phenolic antioxidants on the mutagenicity of aflatoxin B1.
Shelef LA; Chin B
Appl Environ Microbiol; 1980 Dec; 40(6):1039-43. PubMed ID: 7458309
[TBL] [Abstract][Full Text] [Related]
3. Effect of butylated hydroxytoluene and butylated hydroxyanisole on the mutagenicity of 3,2'-dimethyl-4-aminobiphenyl.
Reddy BS; Sharma C; Mathews L
Nutr Cancer; 1983; 5(3-4):153-8. PubMed ID: 6366755
[TBL] [Abstract][Full Text] [Related]
4. Butylated hydroxyanisole, butylated hydroxytoluene and tert.-butylhydroquinone are not mutagenic in the Salmonella/microsome assay using new tester strains.
Hageman GJ; Verhagen H; Kleinjans JC
Mutat Res; 1988 Jul; 208(3-4):207-11. PubMed ID: 3041273
[TBL] [Abstract][Full Text] [Related]
5. Effects of dietary fats and butylated hydroxytoluene on mutagen activation in rats.
Ponder DL; Green NR
Cancer Res; 1985 Feb; 45(2):558-60. PubMed ID: 3967231
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of butylated hydroxytoluene-mediated modulation of 2-acetylaminofluorene mutagenicity in rat and human hepatocyte/Salmonella assays.
Chipman JK; Davies JE; Paterson P
Mutat Res; 1987 Mar; 187(3):105-12. PubMed ID: 3547109
[TBL] [Abstract][Full Text] [Related]
7. Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of gamma-glutamyl transpeptidase-positive foci development in the liver of rats.
Imaida K; Fukushima S; Shirai T; Ohtani M; Nakanishi K; Ito N
Carcinogenesis; 1983; 4(7):895-9. PubMed ID: 6135514
[TBL] [Abstract][Full Text] [Related]
8. The effect of butylated hydroxytoluene on the growth of enzyme-altered foci in male Fischer 344 rat liver tissue.
Lok E; Mehta R; Jee P; Laver G; Nera EA; McMullen E; Clayson DB
Carcinogenesis; 1995 May; 16(5):1071-8. PubMed ID: 7767967
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent reduction of N-2-fluorenylacetamide-induced liver cancer and enhancement of bladder cancer in rats by butylated hydroxytoluene.
Maeura Y; Weisburger JH; Williams GM
Cancer Res; 1984 Apr; 44(4):1604-10. PubMed ID: 6704970
[TBL] [Abstract][Full Text] [Related]
10. Review of the mutagenicity/genotoxicity of butylated hydroxytoluene.
Bomhard EM; Bremmer JN; Herbold BA
Mutat Res; 1992 Sep; 277(3):187-200. PubMed ID: 1381049
[TBL] [Abstract][Full Text] [Related]
11. Nine-week detection of six genotoxic lung carcinogens using the rasH2/BHT mouse model.
Umemura T; Kodama Y; Nishikawa A; Hioki K; Nomura T; Kanki K; Kuroiwa Y; Ishii Y; Kurokawa Y; Hirose M
Cancer Lett; 2006 Jan; 231(2):314-8. PubMed ID: 16399233
[TBL] [Abstract][Full Text] [Related]
12. The lung tumor promoter, butylated hydroxytoluene (BHT), causes chronic inflammation in promotion-sensitive BALB/cByJ mice but not in promotion-resistant CXB4 mice.
Bauer AK; Dwyer-Nield LD; Hankin JA; Murphy RC; Malkinson AM
Toxicology; 2001 Dec; 169(1):1-15. PubMed ID: 11696405
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the metabolism of butylated hydroxytoluene (BHT) and lung tumor promotion in mice.
Thompson JA; Bolton JL; Malkinson AM
Exp Lung Res; 1991; 17(2):439-53. PubMed ID: 2050043
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the hepatocarcinogenicity of aflatoxin B1 in rats by low levels of the phenolic antioxidants butylated hydroxyanisole and butylated hydroxytoluene.
Williams GM; Iatropoulos MJ
Cancer Lett; 1996 Jun; 104(1):49-53. PubMed ID: 8640745
[TBL] [Abstract][Full Text] [Related]
15. Modulation of benzo[a]pyrene-induced morphological transformation of Syrian hamster embryo cells by butylated hydroxytoluene and butylated hydroxyanisole.
Potenberg J; Schiffmann D; Kahl R; Hildebrandt AG; Henschler D
Cancer Lett; 1986 Nov; 33(2):189-98. PubMed ID: 3791190
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity and apoptosis induction by butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT).
Saito M; Sakagami H; Fujisawa S
Anticancer Res; 2003; 23(6C):4693-701. PubMed ID: 14981915
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of promutagen activation by the antioxidants butylated hydroxyanisole and butylated hydroxytoluene.
McKee RH; Tometsko AM
J Natl Cancer Inst; 1979 Aug; 63(2):473-7. PubMed ID: 287836
[TBL] [Abstract][Full Text] [Related]
18. Safety assessment of butylated hydroxyanisole and butylated hydroxytoluene as antioxidant food additives.
Williams GM; Iatropoulos MJ; Whysner J
Food Chem Toxicol; 1999; 37(9-10):1027-38. PubMed ID: 10541460
[TBL] [Abstract][Full Text] [Related]
19. Lack of carcinogenicity of butylated hydroxytoluene on long-term administration to B6C3F1 mice.
Shirai T; Hagiwara A; Kurata Y; Shibata M; Fukushima S; Ito N
Food Chem Toxicol; 1982 Dec; 20(6):861-5. PubMed ID: 6891670
[TBL] [Abstract][Full Text] [Related]
20. Selective induction of apoptosis in mouse and human lung epithelial cell lines by the tert-butyl hydroxylated metabolite of butylated hydroxytoluene: a proposed role in tumor promotion.
Dwyer-Nield LD; Thompson JA; Peljak G; Squier MK; Barker TD; Parkinson A; Cohen JJ; Dinsdale D; Malkinson AM
Toxicology; 1998 Sep; 130(2-3):115-27. PubMed ID: 9865479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
